Status:
COMPLETED
Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children
Lead Sponsor:
University Hospital, Tours
Conditions:
Adhd
Eligibility:
All Genders
6-15 years
Brief Summary
Attention-deficit with or without hyperactivity disorder (ADHD) is a real health public concern. No easy-use diagnosis tool are available. Metabolomic approaches has brought very usefull data in other...
Eligibility Criteria
Inclusion
- Child or adolescent with symptoms of attention disorders and / or hyperactivity
- aged from 6 to 15 years old
Exclusion
- Failure or refusal of all or part of the multidisciplinary evaluation (medical and / or neuropsychological assessments and / or biological assessments)
- Identification of an intercurrent condition likely to have an impact on metabolomic analyzes (acute infection, fever, etc.)
- Parents or legal guardians opposed to data processing
Key Trial Info
Start Date :
January 29 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 12 2019
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT03436017
Start Date
January 29 2018
End Date
November 12 2019
Last Update
June 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital TOURS
Tours, France, 37044